ULTIMA was featured in issue 25 of Cosmedic by SGMK, the magazine of the Swiss Society for Medical Cosmetics. Roland Wagner’s article is presented below in an edited English version. A note at the end clarifies how its professional claims should be interpreted.
ULTIMA FACE Lift – simple, smart, painless
The E-Fit ULTIMA non-surgical facial treatment focuses on a natural, youthful appearance. HILEFT – High Intensity Light and Electro Facial Therapy – complements surface-level skincare with muscle stimulation and light treatment to support a firmer appearance. By Roland Wagner.
What treatments do clients look for?
The author describes demand for innovative, painless treatments with quickly noticeable effects and as few unwanted effects as possible. He questions the tendency to repackage established procedures instead of pursuing substantive development, with new product names or appearances sometimes taking the place of technological innovation.
Device manufacturing built around development
Active in medical aesthetics since 2010, Wagner seeks manufacturers that bring fresh thinking to the field. He presents Budapest-based E-Fit Ltd. as a company where research, development and advanced professional qualifications have a central role. The article highlights researchers, staff with doctoral qualifications and a well-qualified support team, alongside the ambition to develop uncompromising innovations under the ULTIMA brand. At the time of publication, it discusses the launch of ULTIMA FACE and further projects progressing through MDR compliance, with new developments anticipated for 2025.
Which technologies does ULTIMA FACE combine?
The article describes ULTIMA FACE as a non-invasive facial system combining electrical muscle stimulation (EMS) with LED light therapy. It introduces E-Fit’s patented IST+ technology and the HILEFT approach, and refers to a 120-watt light source at 730 and 940 nm. It relates the research background on EMS and light therapy to skin and muscle responses. It also discusses creatine kinase (CK), an enzyme associated with muscle loading, and changes observed after EMS. A CK response is not a direct measure of aesthetic effectiveness, and general EMS data cannot automatically be extrapolated to a facial treatment.
Who is interested in ULTIMA treatments?
The author highlights demand for non-surgical, comfortable procedures aimed at quickly noticeable changes. He compares this with the popularity of injectable treatments, mentioning collagen, hyaluronic acid, calcium- and lactic-acid-based products, and botulinum toxin type A. ULTIMA is discussed as a possible alternative or a professionally planned complementary approach. The article considers the relationship between long-term muscle weakening and muscle volume, then highlights targeted activation of the frontalis, masseter, buccinator and zygomatic muscles. Reliable elimination of botulinum toxin-related muscle atrophy is not, however, a substantiated treatment promise. The intended audience is clients seeking a more natural facial appearance and approach to skincare.
How is the treatment plan structured?
The article emphasises assessment of contraindications, including pacemakers, and gentle skin preparation. Citing the manufacturer’s report at the time, it mentions six weekly 30-minute sessions followed by maintenance treatments, and draws attention to adequate fluid and nutrient intake. Before-and-after photographs are available on our Results page. The schedule described is a historical example, not an individual treatment prescription: a qualified practitioner determines the current plan, suitability and frequency.
Roland Wagner holds an Executive MBA FH and is managing director of V-Skin Medical Beauty AG and Laser Clinic Switzerland GmbH, as well as a certified skin and laser specialist. Contact: vskin.ch; TikTok: @laserclinicschweiz.
Editorial note: this historical report includes professional clarifications. Research observations, author opinions and participant experiences do not establish a guaranteed treatment outcome for everyone.

